GlobeNewswire Inc | Apr 20, 2021 08:00AM EDT

April 20, 2021

RALEIGH, N.C., April 20, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its first quarter 2021 financial results before the open of the U.S. financial markets onThursday, May 6, 2021. The Company will host a conference call and webcast at 8:30 AM Eastern Timeto discuss the results and provide an update on business operations.

Conference Call Dial-In & Webcast Information:

Date: Thursday, May 6, 2021 Time: 8:30 AM Eastern Time Domestic: 877-407-0789 International: 201-689-8562 Conference ID: 13718097 Webcast: http://public.viavid.com/index.php?id=144116

AboutBioDelivery Sciences International, Inc.BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products address serious and debilitating conditions, including chronic pain and opioid-induced constipation.

2021BioDelivery Sciences International, Inc. All rights reserved.

Contact:Bob YedidLifeSci Advisors646-597-6989Bob@LifeSciAdvisors.com